Dailypharm Live Search Close

How to stabilize supply of national essential medicines

By Lee, Hye-Kyung | translator Alice Kang

24.10.18 05:10:53

°¡³ª´Ù¶ó 0
NA Health and Welfare Committee points out issues¡¦.MFDS responds, ¡®under MOHW jurisdiction¡¯

Changed the supply discontinuation drug reporting criteria from 60¡æ180 days...will be enforced in April next year


While prescribing drugs by ingredient name and introducing international nonproprietary names (INNs) are being discussed as measures to stabilize the supply of drugs, voices have emerged calling for a system that allows the use of the same ingredient drugs as nationally essential medicines.

The issue of stabilizing the supply of not only national essential medicine but also drugs that are constantly experiencing supply and demand instability is one of the most frequent questions asked by the National Assembly's Health and Welfare Committee's national audit this year.

According to the written inquiries submitted by the MFDS to the National Assembly on the 17th, 7 lawmakers - Yoon Kim, He

Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)